ArticleTrials2020

An optimised dosing regimen versus a standard dosing regimen of vancomycin for the treatment of late onset sepsis due to Gram-positive microorganisms in neonates and infants aged less than 90 days (NeoVanc): study protocol for a randomised controlled trial.

Louise F Hill et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.